Cell-Based Biosensor to Report DNA Damage in Micro- and Nanosystems by Fendyur, Anna et al.
Cell-Based Biosensor to Report DNA Damage in Micro- and
Nanosystems
Anna Fendyur, Sarvesh Varma, Catherine T. Lo, and Joel Voldman*
Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 77 Massachusetts Avenue,
Room 36-824, Cambridge, Massachusetts 02139, United States
*S Supporting Information
ABSTRACT: Understanding how newly engineered micro- and
nanoscale materials and systems that interact with cells impact cell
physiology is crucial for the development and ultimate adoption of
such technologies. Reports regarding the genotoxic impact of
forces applied to cells in such systems that can both directly or
indirectly damage DNA emphasize the need for developing facile
methods to assess how materials and technologies aﬀect cell
physiology. To address this need we have developed a TurboRFP-
based DNA damage reporter cell line in NIH-3T3 cells that
ﬂuoresce to report genotoxic stress caused by a wide variety of
agents, from chemical genotoxic agents to UV-C radiation. Our
biosensor was successfully implemented in reporting the genotoxic
impact of nanomaterials, demonstrating the ability to assess size
dependent geno- and cyto-toxicity. The biosensor cells can be assayed in a high throughput, noninvasive manner, with no need
for overly sophisticated equipment or additional reagents. We believe that this open-source biosensor is an important resource
for the community of micro- and nanomaterials and systems designers and users who wish to evaluate the impact of systems and
materials on cell physiology.
The use of micro- and nanoscale technologies for biologicaland medical applications has rapidly advanced in recent
years. These technologies have been applied in techniques and
platforms for toxicology assessment,1,2 organ-on-a-chip devices
for tissue-engineering,3−5 biomedical microelectromechanical
systems (Bio-MEMS) for microscale cell manipulation and
assessment,6−8 and nanomaterial-based drug delivery sys-
tems.9,10 Such approaches oﬀer low-cost and/or new
functionality for biological, chemical, pharmaceutical, and
environmental applications. Critical in the development of
newly engineered micro- and nanoscale materials and systems
that interact with cells is the understanding how they impact
cell physiology. The geometry and chemistry of nanomaterials
and the forces applied on cells in microsystems can both aﬀect
cell physiology. Reports regarding the cytotoxic impact of
techniques and materials in wide use today2,11−14 emphasize
the importance of developing facile methods to assess how
materials and technologies aﬀect cell physiology. DNA damage
in particular can occur via a variety of mechanisms that are
relevant to micro- and nanosystems. Forces applied to cells in
such systems can both directly or indirectly damage DNA via
reactive oxygen species (ROS).11,15−21 Exposure of cells to light
of varying wavelengths,21 heat,22 electric ﬁelds,19 and magnetic
ﬁelds23 has been linked to direct or indirect DNA damage.
ROS-induced DNA damage can be caused by a variety of
nanomaterials used for biomedical applications,2,12−14,24,25
including commercially available silver nanoparticles (Ag-
NPs),14,26 which have a number of therapeutic uses.27
One important concern when developing microsystems and
nanomaterials for biomedical applications is with sublethal
genotoxic eﬀects. Some of these eﬀects can disrupt DNA
integrity without leading to overt cell death and therefore can
remain elusive when examining viability. To assay such
sublethal genotoxicity, one would ideally want a nondestructive,
quantitative, high-throughput assay that is also reagent-free, in
order to simplify the assay and limit the interactions of tested
microsystems and nanomaterials with any added reagents. Such
an assay would allow the biomedical technology designer or
user to optimize their newly developed system or material. The
genotoxicity assays that are used today include gene expression
assays (via RT-PCR),28 single-cell gel electrophoresis assay
(comet assay),29 γ-H2AX assay,30 and micronucleus (MN)
assay.31 These methods require additional reagents, signiﬁcant
sample preparation, and biological expertise, and they can be
diﬃcult to apply to assess nanomaterials and microsystems
because these assays may be incompatible with the technology
under development (e.g., limited access to cells in a
microsystem). Moreover, as the methods are end point, they
prevent further assessment of the cells’ recovery and long-term
survival.
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Methods based instead on engineering cells that ﬂuoresce to
report DNA damage have the potential to be reagent-free,
simple, and nondestructive. Indeed, development of cell-based
toxicity tests is of growing interest, and several genotoxicity-
reporting cell-based sensors have become commercially
available: the CellSensor beta-lactamase ratiometric ﬂuores-
cence resonance energy transfer (FRET)-based reporter assay
(Invitrogen)32 and the GreenScreen assay (Gentronix Ltd.).33
These assays oﬀer a high-throughput alternative for DNA
damage detection. However, the requirements for specialized
equipment and software needed for FRET-based measure-
ments, the lack of consensus between diﬀerent cell biosensor
assays on the reporting gene selected or the ﬂuorophore
used,32−34 and the costliness of the commercially available
sensors emphasize the need to expand the toolbox of available
genotoxicity monitoring techniques for use by the nano- and
microsystems community for evaluation and optimization of
their newly developed systems and materials. The use of the
green ﬂuorescent protein (GFP) as a reporting ﬂuorophore for
the aforementioned commercial assay further introduces
constraints limiting multiple ﬂuorescent labeling, since GFP
emission shows a substantial overlap with other ﬂuorophores.
Here we introduce an open-source cell-based biosensor
speciﬁcally engineered to report DNA damage induced by
micro- and nanosystems. The biosensor cells express
TurboRFP (red ﬂuorescent protein) ﬂuorescence allowing
visual and nondestructive assessment of gene expression with
single-cell resolution using commonly available equipment to
quantify the cellular ﬂuorescence response without requiring
additional reagents and materials, large numbers of cells, or
overly sophisticated microscopy. We have developed a
transcriptional sensor that reports on activation of p21 protein
(cyclin-dependent kinase inhibitor), a crucial node in the DNA
damage pathway. We describe the quantitative characterization
of the biosensor as well as its application to detect stresses
caused by nanomaterials or found in microsystems, speciﬁcally
Ag-NPs and ROS. The DNA-damage-reporting biosensor
presented here oﬀers new possibilities for user-friendly and
cost-eﬃcient assessment of DNA damage in a variety of nano-
and microsystems.
■ MATERIALS AND METHODS
Cell Culture. NIH-3T3 cells, obtained from ATCC, were
cultured in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM)
supplemented with 10% (v/v) bovine calf serum (Hyclone),
2% (v/v) L-glutamine, and 1% (v/v) penicillin-streptomycin.
All cell culture reagents were from Invitrogen unless otherwise
noted. Cells were grown at 37 °C in a humidiﬁed incubator
with 5% CO2. For experiments, cells were plated to reach 70%
conﬂuence.
Engineering the DNA Damage Cell-Based Biosensor.
We engineered a reporter gene construct encoding the
ﬂuorescent TurboRFP protein, the expression of which is
under the control of the p53-responsive p21 promoter (refer to
the Supporting Information, Methods for a detailed summary
of the procedure and the sequence of the p53-responsive p21
promoter region). This plasmid was deposited to Addgene (the
plasmid number is 52432). The NIH-3T3 cells were transfected
using Superfect (Qiagen), selected using selection medium
containing 1 mg/mL genetecin (G418) for stably transfected
clones, and single-cell cloned (see the Supporting Information,
Methods for a more detailed procedure). The isogenic clones
were expanded and then assayed to ﬁnd the clone with the
highest ﬂuorescent response to DNA damage.
Quantitative Characterization of the Biosensor Using
DNA-Damaging Agents. DNA damage was induced with
well-characterized DNA-damaging agents: methylmethanesul-
fonate (MMS; Sigma-Aldrich) and UV-C (254 nm) by using a
Spectrolinker XL-1500 UV cross-linker (Spectronics Corpo-
ration). MMS was diluted in cell culture medium not
supplemented with bovine calf serum immediately before use
at concentrations of 0.05−1.5 mM. Cells were incubated in cell
culture medium with MMS for 4 h, then washed with PBS, and
incubated in normal cell culture medium until further analysis.
The control cells were exposed to the same medium without
MMS and to the same number of washes. Cellular response to
UV induced DNA damage was assessed using doses of 8, 20,
and 35 J/m2. Biosensor cells were washed with PBS prior to the
UV exposure and after the exposure incubated in normal cell
culture medium until further analysis. The control cells were
placed outside the incubator for the same amount of time as
UV-exposed biosensor cells and were washed the same number
of times with PBS. The red ﬂuorescence response of the
biosensor cells was determined at diﬀerent time points after
exposure using ﬂow cytometry (FC).
Pathway Validation. To assess the dependence of
TurboRFP expression on p53-pathway activation, the biosensor
cells were transfected with p53 shRNA (small hairpin RNA)
plasmid (Addgene plasmid 12090) directed against mouse
p53.35 Enhanced-GFP (EGFP) is expressed from this plasmid
as a marker. EGFP-positive cells were isolated after 6 days using
a MoFlo ﬂow sorter and expanded for 7 days before MMS
induction. Cells were exposed to MMS for 4 h and analyzed
after 24 h.
Cell Viability. Cell viability following exposure to diﬀerent
MMS concentrations was assessed by staining cells (including
the cells in supernatant) with 1 μM Sytox-Blue (Invitrogen) for
5−30 min and analyzing them using FC. The percentage of
dead cells was determined by Sytox-Blue positive cells. The
fold-induction of red ﬂuorescence was determined from the
Sytox-Blue-negative cell population.
Comet Assay. Biosensor cells were treated with MMS
diluted in cell culture medium not supplemented with bovine
calf serum at concentrations of 0.05−1.5 mM. The control cells
were exposed to the same medium without MMS and to the
same number of washes. The comet assay was done as
previously described36 (see the Supporting Information,
Methods for a more detailed procedure).
Treatment of the DNA Damage Biosensor with Ag-
NPs. Spherical Ag-NPs (10 nm, 100 nm) were purchased from
nanoComposix as 1 000 mg/L in a 2 mM sodium citrate buﬀer
(BioPure aqueous suspensions) and were stored in the dark at
4 °C. Dilutions were created by mixing with cell culture
medium. Biosensor cells were exposed to 1−100 μg/mL of
silver nanoparticles for 12−48 h, trypsinized, and analyzed
using FC. Control biosensor cells were exposed to cell culture
medium with sodium citrate buﬀer.
Quantitative Characterization of the Sensor in
Response to H2O2 Exposure. The DNA damage biosensor
cells were exposed to the culture medium containing the
indicated concentration of H2O2 (25−500 μM), with or
without catalase (100 mg/mL; Sigma-Aldrich), for 4 h, at which
time cells where washed and incubated in normal cell culture
medium until further analysis. The response of biosensor cells
to H2O2 was compared to the response of cells pretreated with
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catalase (100 mg/mL; Sigma-Aldrich) for 2 h prior to adding
H2O2.
Imaging. Images were acquired with an Axiovert 200 M
microscope (Zeiss) ﬁtted with a cooled CCD camera LaVision
ImagerQE (LaVision) and an automated stage Ludl MAC 5000
(Ludl) using 10× and 20× objectives. Metamorph software
(Molecular Devices) was used to control the microscope.
Fluorescent images were acquired using a TRITC ﬁlter (for
TurboRFP) and FITC ﬁlter for EGFP. Images were analyzed
using ImageJ.
Flow Cytometry Analysis. The biosensor cells were
trypsinized (Gibco), diluted in FACS buﬀer (95% (v/v) PBS,
5% (v/v) BCS, 1% (v/v) penicillin-streptomycin), and
transported on ice to the Swanson Biotechnology Center
Flow Cytometry Facility (Koch Institute, MIT). The red
ﬂuorescence response of the DNA damage reporter cells was
analyzed by an LSR II HTS ﬂow cytometer (BD Biosciences)
using a PETexasRed-YG-A (Red channel) ﬁlter (561 nm
excitation and 610 ± 20 nm emission). The FITC channel (488
nm excitation and 530 ± 30 nm emission wavelengths) was
used either as a reference channel or for green ﬂuorescence
(EGFP) detection. Side scatter (SSC) and forward scatter
(FSC) gates were set to exclude debris. Untransfected NIH-
3T3 cells and stable RFP-expressing cells were used as controls.
A minimum of 1500 events was collected per sample. The
maximum background ﬂuorescence from the untransfected
NIH-3T3 cells was set as the threshold and the cells with the
red ﬂuorescent values above this threshold were termed
“activated cells”. To obtain the fold-induction of the red
ﬂuorescence of biosensor cells in response to DNA damage, the
mean red ﬂuorescence of the cells exposed to a DNA damaging
agent was divided by the mean red ﬂorescence of the control
(not exposed to genotoxic agent) population of biosensor cells.
Flow cytometry data was collected and analyzed using
FACSDiva (San Jose, California) and FlowJo (Ashland, OR)
software.
Statistical Analysis. The statistical signiﬁcance of the
diﬀerences between fold-inductions of mean red ﬂuorescence
was conducted using two-tailed Student’s t test, considering p <
0.05 as signiﬁcant and one-way ANOVA and Dunnett’s test
with P < 0.05 (GraphPad Prism 5 software) to compare the
fold-induction of red ﬂuorescence caused by diﬀerent
concentrations of the stressors to the fold-induction of the
control cells at each time point. The control biosensor cells
were exposed to the same conditions as the stressed biosensor
cells, except the stressor agent itself and were compared to the
untreated biosensor cells to measure their red ﬂuorescence fold-
induction. For all analysis: ∗ = p-value < 0.05.
■ RESULTS
Selection of the DNA Damage-Reporting Cell-Based
Biosensor. Cells respond to DNA damage by halting cell cycle
progression, which leads to p53-mediated cell cycle arrest37 in
order to enable the cell to perform DNA repair processes.
Genes that are activated in response to DNA damaging stress
have been extensively studied and characterized;37−39 they
include the canonical p53 pathway. The major downstream
target gene of active p53 transcription factor is p21 (cyclin-
Figure 1. (A) Left panel, FC scatter plots of TurboRFP intensity (y axis; arbitrary units) in response to MMS (1 mM) of two clones, 81 and 19
(blue-control unstressed cells; red-cells exposed to MMS); right panel, RFP intensity distribution histogram for clones 81 and 19 after exposure to
MMS (red) compared to control (blue). (B) Phase (left) and ﬂuorescence (right) images of clone 81 cells before and after 1 mM MMS exposure for
4 h. Images were taken 24 h after the exposure. Stressed cells expressed the red ﬂuorescence, showing visible activation of the reporter. Scale bar 100
μm.
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dependent kinase inhibitor),40,41 which inhibits both the
transition from G1 to S and from G2 to mitosis,41,42 as well
as DNA replication.43 Elevation of p21 expression in response
to DNA damage has been previously found both in vivo and in
vitro.44−46 Hence, our approach for creating a biosensor to
report on DNA damage was to construct a cell-cycle arrest
sensor by fusing the p53-responsive p21 promoter with the
ﬂuorescent reporter protein TurboRFP, similar to an approach
previously implemented in our lab to develop a cell-based
biosensor to report on heat shock pathway activation.47
We chose to create the sensor in the NIH-3T3 cell line as it
is a commonly used ﬁbroblast cell line that is simple to culture,
the DNA damage response has been extensively studied in
these cells, and they express wild-type p53 protein.48,49 We
created a plasmid containing the full-length (667 base-pairs)
p21 promoter upstream of TurboRFP (Figure S1 in the
Supporting Information). Upon stable transfection we single-
cell cloned the mixed population of cells to achieve a clonal
population. Clones that stably incorporate foreign DNA can
demonstrate a wide variation in recombinant gene expression.
The reason for this can be the positional eﬀects, in which
diﬀerent regions of the chromosome modulate transgene
expression. In order to minimize this heterogeneity and to
achieve more consistent performance we used an approach that
was previously used for cell-based toxicity assay development,
namely, selecting the highest producing clone.34,47 We
examined the clones for RFP induction and for the percentage
of positive cells, setting the threshold for determining positive
cells from the brightest autoﬂuorescence signal from
untransfected NIH-3T3 cells. The screening of the clones for
RFP induction was performed using ﬂow cytometry after
exposure of the cells to methylmethanesulfonate (MMS) as a
genotoxic agent. MMS is a DNA alkylating agent that causes
random single- and double-strand DNA breaks. It is a well-
characterized DNA damaging agent that induces the transitory
delay of DNA replication. Its ease of use and its rapid uptake by
cells made it a reagent of choice for selection and character-
ization of the DNA-damage reporter clone. Cells were exposed
to MMS (1 mM) for 4 h and analyzed 24 h later using FC.
We screened 50 clones (Figure S2 in the Supporting
Information). As expected, each clone had diﬀerent character-
istics regarding the expression of red ﬂuorescent protein before
and after induction (Figure S2 in the Supporting Information).
We compared diﬀerent clones according to the fold-induction
of the mean red ﬂuorescence and the percentage of positive
cells.
Examining two clones in detail (clone 81, clone 19) gives
insight into the diﬀerent responses observed (Figure 1A). The
control populations of these clones diﬀer in % positive and in
mean intensity: clone 19 had 2.85% positive cells with mean
ﬂuorescence of the entire control population of 60.8 (arbitrary
units), whereas clone 81 cells that had only 0.029% positive red
cells with a mean red ﬂuorescence of 38.5 (arbitrary units) 24 h
after exposure to MMS (1 mM). Clone 81 cells showed a
substantial population shift (Figure 1A), with 74.5% cells
expressing RFP (mean ﬂuorescence 3331, 86.5 times higher
than the control), compared to clone 19 with only 16.6% red
cells after induction with mean ﬂuorescence intensity of 191
(Figure 1A), only 3 times higher than the mean ﬂuorescence
intensity of the control population. After analyzing all 50
clones, we found that clone 81 displayed both the highest fold-
induction of the mean red ﬂuorescence and the highest
percentage of red cells. Because of both the low red
ﬂuorescence signal of the control unstressed cells and the
high induction of the RFP after exposure to genotoxic agent, as
compared to other clones, clone 81 was selected as our
biosensor. Additionally, to demonstrate that the selected
biosensor cells are amenable to assessment by microscopy,
imaging before and after DNA damage induction showed
visible activation of the reporter (Figure 1B).
Validation of the Dependence of TurboRFP Expres-
sion on p53-Pathway Activation. To assess the speciﬁcity
of our biosensor, we examined its response upon pathway
inhibition. We knocked down p53 by transfecting the sensor
with a plasmid containing an EGFP (enhanced GFP) marker
and a p53 shRNA (small hairpin RNA) directed against mouse
p53. Cells that were EGFP-negative turned red upon MMS
induction, whereas EGFP-positive cells were not red (Figure
2A,B). Fold-induction of mean red ﬂuorescence was 16 ± 0.5 in
EGFP− cells and was signiﬁcantly reduced to 5.6 ± 0.3 in -
EGFP+ cells (P < 0.05) (Figure 2A,C), indicating that cells that
were transfected with p53 shRNA (green) were inhibited in
their ability to express TurboRFP. This inhibition demon-
strated that p53 is required for RFP expression in our
biosensors and thus that the expression of TurboRFP is driven
by p53-induced transcription.
Response of DNA Damage Biosensors to MMS. We
next characterized the dynamics and dose-dependence of the
DNA damage biosensor response to MMS. MMS concen-
trations above 0.65 mM caused signiﬁcant red ﬂuorescence
induction compared to the controls (Figure 3A). Higher MMS
concentrations resulted in a graded dose-dependent increase in
fold-induction of TurboRFP levels, reaching the highest
response using an MMS concentration of 1 mM. Above this
concentration, cells displayed no additional increases in fold-
induction of red ﬂuorescence signal, reaching a plateau. At
concentrations of 1.2 mM and above, fold TurboRFP induction
decreased, consistent with the observation that at these
concentrations the percentage of dead cells started to increase
above the baseline (Figure S3A in the Supporting Information),
indicating the onset of MMS cytotoxicity. Since dead cells tend
to be lost during sample processing for FC, the ﬂuorescence
decrease in Figure 3A likely occurred due to the loss of the
brightest (and thus most damaged) cells as they die.
Correlation of fold-induction obtained 24 h after exposure
with single-cell comet assay36 (Figure S3B,C in the Supporting
Information) at MMS concentrations of 0.05−1 mM conﬁrmed
a monotonic relationship between DNA damage and fold-
induction of red ﬂuorescence, showing a linear relationship
between the red fold-induction and DNA damage measured by
comet assay starting from 36% DNA in the tail (R2 = 0.99)
(Figure S3C in the Supporting Information).
Next we examined the dynamics of activation. The rise in
TurboRFP ﬂuorescence in response to MMS was time-
dependent, as reﬂected in the increase of the mean red
ﬂuorescence fold-induction over time, with diﬀerent concen-
trations of MMS exhibiting diﬀerent dynamics (Figure 3B).
After 12 h, the biosensor cells exposed to 0.5 and 1 mM MMS
concentrations showed signiﬁcant increase in expression of
TurboRFP. After 24 h, the ﬂuorescence of cells exposed to 0.5
mM MMS plateaued and then decreased after 36 h, suggesting
that the cells were recovering from the stress. Fluorescence in
cells exposed to 1 mM MMS stayed elevated for at least 48 h.
DNA-Damage Biosensors’ Response to UV Radiation.
To assay the response of the biosensor to other common DNA
damaging agents, we exposed it to UV-C radiation. Using
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radiation allowed us to induce DNA damage free from
limitations of chemical uptake and metabolism.50 UV-C is a
well-characterized genotoxic agent that is used to study DNA
damage and repair.51 Recently it has become relevant in various
medical applications, including acting as an anticancer agent52
and as a disinfectant for localized treatments of multidrug-
resistant infections.53 Cells exposed to 20 J/m2 and 35 J/m2
doses of UV-C showed a signiﬁcant increase in ﬂuorescence
after 12 h (Figure 4). Biosensor cells’ response to 20 J/m2 and
35 J/m2 UV-C showed further induction after 24 h, with higher
levels of fold-induction in response to 35 J/m2. This response
stayed relatively constant for up to 48 h.
DNA-Damage Biosensors’ Response to Silver Nano-
particles (Ag-NPs). To demonstrate the use of the biosensor
in a nanotechnological application, we implemented it to assay
Figure 2. (A) Phase and ﬂuorescence images of p53 shRNA
transfected DNA damage biosensor cells expressing EGFP (green)
without (controls) and with (MMS) exposure to 1 mM MMS. Scale
bar is 100 μm. Cells that express EGFP did not exhibit red
ﬂuorescence. (B) FC scatter plots of p53 shRNA transfected
biosensors’ TurboRFP signal of controls (left) and exposed to MMS
(right). (C) Fold-induction of red ﬂuorescence of p53 shRNA-
transfected cells in response to MMS. EGFP− cells are derived from
Q1 and Q4 of part B, right scatter plot, and EGFP+ cells are from Q2
and Q3 of part B, right scatter plot.
Figure 3. (A) Mean fold-induction of TurboRFP expression in
biosensor cells treated with increasing MMS concentrations; analyzed
using FC 24 h after 4 h exposure. (B) Time dependence of fold-
induction of TurboRFP expression in response to diﬀerent MMS
concentrations (n ≥ 3; error bars, standard error of mean).
Figure 4. Dose and time response of DNA-damage biosensor cells to
UV-C. Exposed cells were analyzed using FC at diﬀerent time points
after exposure, and the mean red ﬂuorescence intensity was compared
to the mean red ﬂuorescence intensity of the control biosensor cells (n
= 3; error bars, standard error of mean).
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genotoxicity of Ag-NPs. Ag-NPs are widely used in biomedical
research and for therapeutic purposes due to their electrical
conductivity54 and antimicrobial properties.27 Recent reports
about the genotoxic potential of this nanomaterial has sparked
signiﬁcant interest in this aspect of Ag-NPs’ impact on cell
physiology.14,26 Here a beneﬁt of the biosensor is the simplicity
of assay: simply add the Ag-NPs into a microtiter plate
containing the cells and then read on a ﬂow cytometer, allowing
assay of many conditions (particle types, concentrations, and
durations). Exposure of biosensor cells to Ag-NPs and analysis
of their red ﬂuorescence induction using FC showed a
signiﬁcant response to 10 and 100 nm Ag-NPs at
concentrations of 50 and 100 μg/mL starting at 12 h of
exposure (Figure 5). After 24 h of exposure to 10 μg/mL of 10
nm Ag-NPs, biosensor cells exhibited a signiﬁcant fold-
induction of red ﬂuorescence, similar to the response of 100
μg/mL of the 100 nm Ag-NPs, suggesting that the 10 nm
nanoparticles were more genotoxic than the 100 nm nano-
particles. Lower concentration of 10 nm NPs resulted in no
signiﬁcant ﬂuorescence induction. For the 100 nm NPs after 48
h of exposure, 50 μg/mL caused signiﬁcant TurboRFP
induction, as high as that caused by 10 μg/mL of the 10 nm
Ag-NPs. Exposure of cells to 100 μg/mL of the 100 nm Ag-NPs
after 48 h resulted in a decrease in mean fold-induction of red
ﬂuorescence, probably due to the decrease in cell viability
caused by the long exposure (Figure S4 in the Supporting
Information). For the 10 nm Ag-NPs, meanwhile, concen-
trations of 50 and 100 μg/mL resulted in signiﬁcant cell loss
(Figure S4 in the Supporting Information). The apparent
increased toxicity of the smaller Ag-NPs is in agreement with
published reports assaying the size-dependent toxicity of Ag-
NPs.55,56
DNA-Damage Biosensors’ Response to Oxidative
Stress. Oxidative stress is a common adverse outcome caused
by various forces and materials used or generated in micro- and
nanosystems, such as electric ﬁelds,57 heat,47 and various
nanoparticles,2,13,14,24 which perturbs the balance between
intracellular formation and degradation of ROS. Reﬂecting
the importance of ROS as a stress agent, we characterized the
response of the biosensor to ROS. Addition of exogenous H2O2
mimics cellular oxidative stress because of the permeability of
cell membranes to this small molecule. Sensors exposed to
diﬀerent concentrations of hydrogen peroxide showed time-
and dose-dependent induction of ﬂuorescence (Figure 6).
Signiﬁcant induction of TurboRFP expression was observed for
H2O2 concentrations ≥100 μM 12 h after exposure.
Fluorescence of cells exposed to 500 μM H2O2 plateaued
after 24 h at a level of fold-induction similar to that reached by
cells exposed to 300 μM H2O2 after 48 h. To determine the
speciﬁcity of the response to ROS, we pretreated biosensor
cells with catalase, a ROS scavenger enzyme. Pretreatment
abrogated induction of TurboRFP expression in response to
H2O2 at all concentrations and times assayed, demonstrating
the speciﬁcity of the damage mechanism.
■ DISCUSSION
Understanding how newly engineered micro- and nanoscale
materials and systems, meant to interact with cells, impact the
physiology of those cells is critical when developing such
systems and for their ultimate adoption. Reports regarding the
cytotoxic impact of micro- and nanoscale techniques and
materials that are in wide use today for biological and medical
applications2,11−14,58 emphasize the importance of developing
facile methods to assess this impact on cell physiology. Viability
is important and straightforward to assess but does not report
on sublethal stresses. Cell morphology and growth can report
on sublethal stresses, but their limited speciﬁcity precludes
identiﬁcation of the causes of any observed changes in
morphology or growth.
Gene expression28 (via RT-PCR), comet assay,29 γ-H2AX
assay,30 and micronucleus (MN) assay31 are common ways to
assess sublethal DNA damage but can be diﬃcult to apply to
micro- and nanoscale materials and systems because the assays
may be incompatible with the technology under development
(e.g., limited access to cells in a microsystem).
Fluorescence reporter assays using stable reporter cell lines
have several appealing features for these applications. First, they
are easy to implement, only requiring a ﬂow cytometer or a
microscope. They are nondestructive to the cells and are thus
compatible with downstream assays (such as a viability assay,
Figure S3A in the Supporting Information). They are typically
reagent-free, and so work with materials and systems with
reagent addition is diﬃcult. All these features lead to
throughputs compatible with testing across diﬀerent conditions.
Indeed several cell-based sensors have been developed to assess
DNA damage.32−34,59 Each is diﬀerent either in the gene whose
activation they report on33 or in the reporter ﬂuorophore
used.32−34 However, the commercially available cell-based
assays, such as CellSensor (Invitrogen) and GreenScreen
assay (Gentronix) are expensive, $10 000 for a vial and $5
000 for a kit, respectively. In addition, these assays have not
Figure 5. Dose and time response of DNA-damage reporter cells to
Ag-NPs. Exposed cells were analyzed using FC at diﬀerent time points
after exposure and the mean red ﬂuorescence intensity was compared
to the mean red ﬂuorescence intensity of the control biosensor cells (n
= 3; error bars, standard error of mean).
Figure 6. Dose and time response of DNA-damage biosensor cells to
H2O2 analyzed using FC. Pretreatment of the biosensor cells with
ROS scavenger enzyme catalase (100 mg/mL) resulted in an
attenuation of the biosensor activation (n = 3; error bars, standard
error of mean).
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been evaluated across diﬀerent types of genotoxic stressors.
Also when the GreenScreen assay (yeast background cells) was
used to evaluate various engineered nanomaterials, no
measurable genotoxicity was shown for diﬀerent genotoxic
nanoparticles, including 10 nm Ag-NPs, in contrast to the
sensor reported here (Figure 5).60
Here we introduced an open-source biosensor speciﬁcally
engineered to report on DNA damage induced by micro- and
nanosystems. This transcriptional sensor reports on activation
of p21, a crucial and well-characterized node in the DNA
damage and cell cycle arrest pathway, via p53-driven TurboRFP
protein expression. The biosensor allows visual and non-
destructive assessment of gene expression with single-cell
resolution using commonly available equipment to quantify the
cellular ﬂuorescence response without requiring additional
reagents and materials, large numbers of cells, or overly
sophisticated microscopy. We engineered the biosensor cells to
use TurboRFP because of its intracellular stability, which allows
RFP to be assayed over a range of times and because its spectral
characteristics allows it to be more-easily multiplexed with
other assays than a GFP-based reporter. We chose NIH-3T3
cells as the background because they are one of the most
commonly used ﬁbroblast cell lines, are very easy to culture,
express wild type p53 protein, and have been extensively
studied for DNA damage,48,49 showing sensitivity to diﬀerent
types of genotoxic agents. We have also deposited the reporter
plasmid in Addgene for users wishing to create the sensor in
diﬀerent background cells to get speciﬁc stress responses, while
our biosensor is available from us upon request. After validating
that expression of TurboRFP was dependent on the p53
availability, we characterized our biosensor using agents with
known genotoxic function. The biosensor cells were exposed to
a range of concentrations, from very low concentration that did
not induce signiﬁcant ﬂuorescence responses up to concen-
trations that were cytotoxic and caused cell death, in order to
determine the dynamics of the dose- and time-response. Most
genotoxic agents at high enough concentration induced a
signiﬁcant response of the biosensor 12 h after exposure,
including MMS, UV-C, hydrogen peroxide, and Ag-NPs, but at
this time point it was not always possible to distinguish
between responses to diﬀerent doses or concentrations. At
exposure times of ≥24 h it was possible to detect the fold-
induction of red ﬂuorescence caused by lower but nevertheless
genotoxic concentrations of the stressors. Thus, it is likely that
for most applications read-out at ∼24 h following exposure will
be optimal. This read-out time is similar to those of
commercially available cell-based assays, which also range
between 24 and 48 h. The sensitivity of our biosensor for MMS
genotoxicity detection is similar to that of the GreenScreen
assay.33
To illustrate use cases for both nanomaterials and micro-
systems, we exposed biosensor cells to Ag-NPs and to hydrogen
peroxide (a common stressor found in microsystems). The
biosensor cells responded to the stressors in ways consistent
with published observations55,56 (e.g., the diﬀerence in apparent
toxicity between 10 and 100 nm diameter Ag-NPs, reporting
higher toxicity for smaller nanoparticles). These assays also
illustrate how designers might interpret the results of assays;
they provide a relative measure of genotoxicity rather than an
absolute one. In practice, then, we envision users comparing
fold-induction across conditions/systems and picking the
condition/system with the minimal fold-induction, rather
than use the fold-induction as an absolute metric of
genotoxicity.
■ CONCLUSION
We have develop a TurboRFP-based DNA damage reporter cell
line in NIH-3T3 cells that showed the ability to report
genotoxic stress caused by wide variety of agents, from chemical
genotoxic agents to UV-C radiation. In addition, the biosensors
were successfully implemented in reporting the genotoxic
impact of nanomaterials, demonstrating the ability to assess size
dependent geno- and cyto-toxicity. The biosensor cells can be
assayed in a high-throughput, noninvasive manner, with no
need for sophisticated equipment or reagents. This open-source
biosensor now serves as an important resource for the
community of micro- and nanosystems and materials designers
and users who wish to evaluate the impact of the systems and
materials on cell physiology.
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